Cargando…
Long-term follow-up and treatment of congenital alveolar proteinosis
BACKGROUND: Clinical presentation, diagnosis, management and outcome of molecularly defined congenital pulmonary alveolar proteinosis (PAP) due to mutations in the GM-CSF receptor are not well known. CASE PRESENTATION: A 2 1/2 years old girl was diagnosed as having alveolar proteinosis. Whole lung l...
Autores principales: | Griese, Matthias, Ripper, Jan, Sibbersen, Anke, Lohse, Pia, Lohse, Peter, Brasch, Frank, Schams, Andrea, Pamir, Asli, Schaub, Bianca, Muensterer, Oliver J, Schön, Carola, Glöckner-Pagel, Judith, Nicolai, Thomas, Reiter, Karl, Hector, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175167/ https://www.ncbi.nlm.nih.gov/pubmed/21849033 http://dx.doi.org/10.1186/1471-2431-11-72 |
Ejemplares similares
-
Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis
por: Hildebrandt, Jenna, et al.
Publicado: (2014) -
GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders
por: Griese, Matthias, et al.
Publicado: (2015) -
Autoimmune pulmonary alveolar proteinosis in children
por: Griese, Matthias, et al.
Publicado: (2022) -
Congenital Pulmonary Alveolar Proteinosis
por: Hammami, Saber, et al.
Publicado: (2013) -
Pulmonary alveolar proteinosis in a cat
por: Szatmári, Viktor, et al.
Publicado: (2015)